Cases & Deals

  • Home
  • Practices
  • Productos Medix shareholders advised in sale of 34% of capital stock to WAMEX Private Equity

Share

Productos Medix shareholders advised in sale of 34% of capital stock to WAMEX Private Equity

January 2013

Client(s) Productos Medix, S.A. de C.V.

Jones Day advised Dialicels, S.A. de C.V. as shareholders of Productos Medix, S.A. de C.V., a pharmaceutical company that develops medicines and treatments for patients with overweight and obesity conditions, in connection with the sale of 34% of the capital stock of Productos Medix, S.A. de C.V. to WAMEX Private Equity.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.